Table 1 Characteristics of the study population

From: Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study

Factor

No. of cases

%

Year of diagnosis

  

 1993

553

19.8

 1994

552

19.8

 1995

479

17.1

 1996

610

21.8

 1997

600

21.5

Age groups

  

0–39

14

0.5

 40–49

93

3.3

 50–59

312

11.2

 60–69

717

25.7

 70–79

946

33.9

80

712

25.5

Sex

  

 Male

1330

47.6

 Female

1464

52.4

Carstairs deprivation quintile

  

 (Least deprived) 1

510

18.3

 2

600

21.5

 3

594

21.3

 4

527

18.9

 (Most deprived) 5

562

20.1

 Unknown

1

0.0

Previous cancer

  

 No

2611

93.5

 Yes

183

6.6

Charlson co-morbidity index a

  

 None

2160

77.3

 1–2 conditions

95

3.4

3 conditions

539

19.3

Scottish co-morbidity index a

  

 None

1994

71.4

 1 condition

516

18.5

2 conditions

284

10.2

Bed-days co-morbidity index (in 6 months prior to diagnosis) a

  

 None

334

12

 1–4 days

284

10.2

 5–10 days

453

16.2

11 days

1723

61.7

Bed-days co-morbidity index (between 6 months and 5 years prior to diagnosis) a

  

 None

1555

55.7

 1–4 days

290

10.4

 5–10 days

296

10.6

11 days

653

23.4

Tumour subsite

  

 Head of pancreas

1263

45.2

 Body of pancreas

112

4.0

 Tail of pancreas

57

2.0

 Other

40

1.4

 Unspecified

1322

47.3

Tumour morphology

  

 Neoplasm, not otherwise specified

222

8.0

 Carcinoma, not otherwise specified

1523

54.5

 Adenocarcinoma, not otherwise specified

902

32.3

 Mucin-producing adenocarcinoma

51

1.8

 Other

96

3.4

Microscopically verified

  

 No

1616

57.8

 Yes

1178

42.2

Metastases within 4 weeks of diagnosis a

  

 No

2023

72.4

 Yes

771

27.6

Presence of ascites recorded a

  

 No

2674

95.7

 Yes

120

4.3

Surgical resection a

  

 No

2663

95.3

 Yes

131

4.7

Other surgery a

  

 No

2102

75.2

 Yes

692

24.8

Biliary stent a

  

 No

2054

73.5

 Yes

740

26.5

Chemotherapy a

  

 No

2646

94.7

 Yes

148

5.3

Radiotherapy a

  

 No

2769

99.1

 Yes

25

0.9

Caseload of main treating consultant a

  

 Unknown

29

1.0

 <5 cases

799

28.6

 5–9 cases

612

21.9

 10–19 cases

460

16.5

20 cases

894

32.0

Caseload of hospital of treatment a

  

 Unknown

29

1.0

 1 case

43

1.6

 2–9 cases

113

4.1

 10–29 cases

132

4.8

30 cases

2477

89.6

Specialty of main treating consultant a

  

 Specialist

230

8.2

 Clinician with an interest in the pancreas

109

3.9

 Nonspecialist

2426

86.8

 Unknown

29

1.0

Total

2794

100

  1. aInformation derived from linked hospital discharge records does not include outpatient diagnostic or procedural information.